Related content

Effects of perinatal exposure to 9 -tetrahydrocannabinol on operant morphine-reinforced behavior

By Gonzalez B.   de Miguel R.   Martin S.   Perez-Rosado A.   Romero J.   Garcia-Lecumberri C.   Fernandez-Ruiz J.   Ramos J.A.   Ambrosio E.  

Pharmacology Biochemistry and Behavior, Vol. 75, Iss. 3, 2003-06 ,pp. : 577-584

Elsevier

Access to resources Recommend Favorite

A drug discovery case history of ‘‘delta-9-tetrahydrocannabinol, cannabidiol’’

By Tanasescu Radu   Rog David   Constantinescu Cris S  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 4, 2011-04 ,pp. : 437-452

Informa Healthcare

Access to resources Recommend Favorite

Tau Protein after Delta-9-tetrahydrocannabinol in a Human Neuroblastoma Cell Line

By Lew G.M.  

General Pharmacology, Vol. 27, Iss. 7, 1996-10 ,pp. : 1141-1143

Elsevier

Access to resources Recommend Favorite

9 -tetrahydrocannabinol enhances cortical and hippocampal acetylcholine release in vivo: a microdialysis study

By Acquas E.   Pisanu A.   Marrocu P.   Goldberg S.R.   Di Chiara G.  

European Journal of Pharmacology, Vol. 419, Iss. 2, 2001-05 ,pp. : 155-161

Elsevier

Access to resources Recommend Favorite

(R)-Methanandamide and 9 -tetrahydrocannabinol-induced operant rate decreases in rats are not readily antagonized by SR-141716A

By Jarbe T.U.C.   Lamb R.J.   Liu Q.   Makriyannis A.  

European Journal of Pharmacology, Vol. 466, Iss. 1, 2003-04 ,pp. : 121-127

Elsevier

Access to resources Recommend Favorite